Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An enteropathy-associated T-cell lymphoma arising from the small intestine, most commonly the jejunum or ileum. Patients usually present with abdominal pain, often associated with intestinal perforation. There is often a history of celiac disease. The lymphoma cells are usually medium-sized to large and form an ulcerating mucosal lesion with invasion of the small intestinal wall. Villous atrophy is present in the adjacent small intestinal mucosa. In a minority of cases the lymphoma cells are medium-sized and form a monomorphic infiltrate.
No clinical trials have been registered for small intestinal enteropathy-associated T-cell lymphoma.
20 publications have been identified in PubMed for small intestinal enteropathy-associated T-cell lymphoma. Research spans Case Report / Case Series (45%), Basic Science / Preclinical (25%), and Review / Meta-Analysis (20%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 45% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
Laboratory research |
5 |
25% |
Research summaries | 4 | 20% |
Disease patterns and progression | 2 | 10% |
Butler K (2026). [PMID: 41782401](https://pubmed.ncbi.nlm.nih.gov/41782401/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Kojima K (2026). [PMID: 41913572](https://pubmed.ncbi.nlm.nih.gov/41913572/). *Vet Pathol*. [Basic Science / Preclinical]
Li MH (2026). [PMID: 41551832](https://pubmed.ncbi.nlm.nih.gov/41551832/). *World J Gastroenterol*. [Review / Meta-Analysis]
Gao Y (2026). [PMID: 41958549](https://pubmed.ncbi.nlm.nih.gov/41958549/). *Front Med (Lausanne)*. [Case Report / Case Series]
Boughanmi F (2026). [PMID: 42057140](https://pubmed.ncbi.nlm.nih.gov/42057140/). *J Med Case Rep*. [Case Report / Case Series]
Dieckman T (2025). [PMID: 39802487](https://pubmed.ncbi.nlm.nih.gov/39802487/). *Gastro Hep Adv*. [Basic Science / Preclinical]
Xiang L (2025). [PMID: 41080542](https://pubmed.ncbi.nlm.nih.gov/41080542/). *Front Immunol*. [Epidemiology / Natural History]
Enache I (2025). [PMID: 40564832](https://pubmed.ncbi.nlm.nih.gov/40564832/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Fan DG (2025). [PMID: 40921667](https://pubmed.ncbi.nlm.nih.gov/40921667/). *Zhonghua Bing Li Xue Za Zhi*. [Case Report / Case Series]
Dhar J (2025). [PMID: 40531299](https://pubmed.ncbi.nlm.nih.gov/40531299/). *Indian J Gastroenterol*. [Case Report / Case Series]
AI-curated news mentioning small intestinal enteropathy-associated T-cell lymphoma
Updated Jul 16, 2026
A new study explores the molecular clonal evolution of enteropathy-associated T-cell lymphoma, highlighting its clinical consequences. This research may provide insights into disease progression and treatment strategies.